Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride in Chinese Patients with BPH
NCT00527605Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Dutasteride with Placebo (2 arms). Primary endpoint: Percent Change From Baseline in the Prostate Volume at 6 months. Started Oct 2007; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00527605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527605.